These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12791172)

  • 21. A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.
    McBride CE; Machamer CE
    J Virol; 2010 Feb; 84(4):1891-901. PubMed ID: 20007283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors.
    Zhang Y; Zheng N; Nan P; Cao Y; Hasegawa M; Zhong Y
    Comput Biol Chem; 2007 Apr; 31(2):134-7. PubMed ID: 17368104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.
    Ho TY; Wu SL; Cheng SE; Wei YC; Huang SP; Hsiang CY
    Biochem Biophys Res Commun; 2004 Jan; 313(4):938-47. PubMed ID: 14706633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus.
    Sheahan T; Rockx B; Donaldson E; Corti D; Baric R
    J Virol; 2008 Sep; 82(17):8721-32. PubMed ID: 18579604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.
    Liu IJ; Kao CL; Hsieh SC; Wey MT; Kan LS; Wang WK
    Antiviral Res; 2009 Jan; 81(1):82-7. PubMed ID: 18983873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
    Li F
    J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization.
    Chakraborti S; Prabakaran P; Xiao X; Dimitrov DS
    Virol J; 2005 Aug; 2():73. PubMed ID: 16122388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
    Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
    Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
    He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
    Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a major target of neutralizing antibodies.
    He Y
    Adv Exp Med Biol; 2006; 581():539-42. PubMed ID: 17037594
    [No Abstract]   [Full Text] [Related]  

  • 32. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats.
    Liu RY; Wu LZ; Huang BJ; Huang JL; Zhang YL; Ke ML; Wang JM; Tan WP; Zhang RH; Chen HK; Zeng YX; Huang W
    Virus Res; 2005 Sep; 112(1-2):24-31. PubMed ID: 16022898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus.
    Liu L; Fang Q; Deng F; Wang H; Yi CE; Ba L; Yu W; Lin RD; Li T; Hu Z; Ho DD; Zhang L; Chen Z
    J Virol; 2007 May; 81(9):4694-700. PubMed ID: 17314167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.
    He Y; Zhou Y; Wu H; Luo B; Chen J; Li W; Jiang S
    J Immunol; 2004 Sep; 173(6):4050-7. PubMed ID: 15356154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acids 1 to 422 of the spike protein of SARS associated coronavirus are required for induction of cyclooxygenase-2.
    Liu M; Gu C; Wu J; Zhu Y
    Virus Genes; 2006 Dec; 33(3):309-17. PubMed ID: 16991002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.
    Berry JD; Hay K; Rini JM; Yu M; Wang L; Plummer FA; Corbett CR; Andonov A
    MAbs; 2010; 2(1):53-66. PubMed ID: 20168090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
    Behloul N; Baha S; Shi R; Meng J
    Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry.
    Corver J; Broer R; van Kasteren P; Spaan W
    Virol J; 2009 Dec; 6():230. PubMed ID: 20034394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.
    Hakansson-McReynolds S; Jiang S; Rong L; Caffrey M
    J Biol Chem; 2006 Apr; 281(17):11965-71. PubMed ID: 16507566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.